Contribution of antiferritin antibodies to diagnosis of giant cell arteritis

Annals of the Rheumatic Diseases

Volumn 72, Issue 7, 2013, Pages 1269-1270

  Régent, Alexis ^a,b   Ly, Kim Heang ^c,d   Blet, Aurélie ^a   Agard, Christian ^e   Puéchal, Xavier ^a,b   Tamas, Nicolas ^a   Le Jeunne, Claire ^f   Vidal, Elisabeth ^c,d   Guillevin, Loïc ^b   Mouthon, Luc ^a,b  

^a INSTITUT COCHIN   (France)

^b Assistance Publique Hôpitaux de Paris ^*  (France)

^c DUPUYTREN UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF LIMOGES   (France)

^e HÔTEL DIEU   (France)

^f HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FERRITIN; FERRITIN ANTIBODY; FERRITIN HEAVY CHAIN 1; HEMOGLOBIN; UNCLASSIFIED DRUG;

AGED; AMINO TERMINAL SEQUENCE; ANTIBODY TITER; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DOWN REGULATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; UPREGULATION;

AUTOANTIBODIES; B CELLS; GIANT CELL ARTERITIS;

AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; FERRITINS; GIANT CELL ARTERITIS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 84878389309     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202963     Document Type: Letter

References (9)

1. Ly KH, Regent A, Tamby MC, et al. Pathogenesis of giant cell arteritis: more than just an inflammatory condition? Autoimmun Rev 2010;9:635-45.
2. Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol 2009;21:19-28.
3. Amor-Dorado JC, Garcia-Porrua C, Gonzalez-Gay MA. Anti-endothelial cell antibodies and biopsy-proven temporal arteritis. Lupus 2002;11:134. (Pubitemid 34259447)
4. Navarro M, Cervera R, Font J, et al. Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 1997;6:521-6. (Pubitemid 27371220)
5. Regent A, Dib H, Ly KH, et al. Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach. Arthritis Res Ther 2011;13:R107.
6. Liozon E, Roblot P, Paire D, et al. Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases. Rheumatology (Oxford) 2000;39:1089-94.
7. Baerlecken NT, Linnemann A, Gross WL, et al. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica. Ann Rheum Dis 2012;71:943-7.
8. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8. (Pubitemid 20273297)
9. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA 2002;287:92-101. (Pubitemid 34251681)